Article Versions Notes

Isakova-Sivak I, Stepanova E, Matyushenko V, Niskanen S, Mezhenskaya D, Bazhenova E, Krutikova E, Kotomina T, Prokopenko P, Neterebskii B, et al. Development of a T Cell-Based COVID-19 Vaccine Using a Live Attenuated Influenza Vaccine Viral Vector. Vaccines. 2022; 10(7):1142. https://doi.org/10.3390/vaccines10071142

Isakova-Sivak, Irina, Ekaterina Stepanova, Victoria Matyushenko, Sergei Niskanen, Daria Mezhenskaya, Ekaterina Bazhenova, Elena Krutikova, Tatiana Kotomina, Polina Prokopenko, Bogdan Neterebskii, and et al. 2022. "Development of a T Cell-Based COVID-19 Vaccine Using a Live Attenuated Influenza Vaccine Viral Vector" Vaccines 10, no. 7: 1142. https://doi.org/10.3390/vaccines10071142

Isakova-Sivak, I., Stepanova, E., Matyushenko, V., Niskanen, S., Mezhenskaya, D., Bazhenova, E., Krutikova, E., Kotomina, T., Prokopenko, P., Neterebskii, B., Doronin, A., Vinogradova, E., Yakovlev, K., Sivak, K., & Rudenko, L. (2022). Development of a T Cell-Based COVID-19 Vaccine Using a Live Attenuated Influenza Vaccine Viral Vector. Vaccines, 10(7), 1142. https://doi.org/10.3390/vaccines10071142